Welcome to our dedicated page for 3D Systems news (Ticker: DDD), a resource for investors and traders seeking the latest updates and insights on 3D Systems stock.
3D Systems Corp (symbol: DDD) is a pioneer in the 3D printing industry, offering a broad array of 3D printing and digital manufacturing solutions. The company's product portfolio includes 3D printers for plastics and metals, materials, software, on-demand manufacturing services, and digital design tools. With over 35 years of experience, 3D Systems is at the forefront of innovation in additive manufacturing, impacting a wide range of industries from healthcare and dental to aerospace, automotive, and durable goods.
3D Systems' operations are segmented into Healthcare Solutions and Industrial Solutions, with a significant portion of its revenue generated from the Industrial segment. The company has a strong global presence with offices and facilities across the Americas, EMEA, and APAC regions, although the majority of its revenue comes from the Americas.
The company's recent projects have showcased its advanced capabilities in both industrial and healthcare applications. For instance, 3D Systems has pioneered a first-to-market solution for jetted, monolithic dentures, combining bespoke materials to deliver high-performance dental prosthetics. This innovation has gained interest from leading dental labs and is expected to receive FDA clearance in the second half of 2024.
On the industrial front, 3D Systems continues to expand its portfolio. Recently, the company has seen growth in its metal 3D printing division with Wilting, an industrial machining and metal 3D printing service provider, adding multiple DMP Flex 350 metal 3D printers to its production line. This expansion will enable Wilting to meet increasing customer demand more efficiently.
Financially, 3D Systems has been proactive in managing its liabilities and maintaining a strong balance sheet. The company recently entered into repurchase agreements to buy back $110 million of its 0% Convertible Senior Notes due 2026, thereby reducing its outstanding debt significantly.
3D Systems' commitment to innovation is further exemplified by its developments in patient-specific medical devices. The FDA recently cleared its VSP® PEEK Cranial Implant solution, designed for use in cranioplasty procedures, which utilizes additive manufacturing to produce highly customized, cost-effective cranial implants.
Looking ahead, 3D Systems aims to harness its leadership in digital dentistry, with plans to expand its product offerings to include night guards and direct-printed clear aligners. The company has also secured a multi-year purchase agreement, valued at nearly a quarter-billion dollars, to support the indirect manufacturing process for clear aligners, a testament to its robust 3D printing technology and market leadership.
3D Systems' unique combination of hardware, software, materials, and services, powered by expert application engineers, ensures they continue to transform industries and empower their customers to innovate. More information on 3D Systems is available at www.3dsystems.com.
3D Systems (NYSE:DDD) appointed Mr. Bert Bruce to its Medical Advisory Board to enhance its regenerative medicine initiatives. The board aims to guide efforts in 3D printing vascularized tissues for organ manufacturing and drug development, potentially reducing animal trials. Mr. Bruce, leading the Rare Disease Business Unit at Pfizer, brings over 30 years of pharmaceutical experience. He has a strong background in drug discovery and commercialization. Dr. Jeffrey Graves, CEO, highlighted Bruce's expertise as vital for accelerating the company’s advancements in regenerative medicine and related technologies.
3D Systems (NYSE: DDD) has appointed Dr. Joe Zuiker as Executive Vice President, Engineering and Operations, effective December 12, 2022. Dr. Zuiker brings extensive experience in technical leadership across various industries. Alongside him, Dr. Brent Stucker has been elevated to Chief Technology Officer for Additive Manufacturing. This leadership change aims to bolster 3D Systems' position in the additive manufacturing sector and enhance its product development capabilities as demand for 3D printing increases among customers.
3D Systems (NYSE: DDD) has announced a strategic partnership with Wematter, becoming the exclusive worldwide distributor of the Wematter Gravity Selective Laser Sintering (SLS) solution. This compact, affordable SLS system, designed for diverse applications including medical and automotive industries, occupies less space while delivering a larger build volume. The Gravity allows for easy installation, cloud connectivity, and efficient recycling of materials, offering a cost-effective solution for manufacturers. It will be expanded to the Americas and Asia Pacific by Q2 2023.
3D Systems (NYSE: DDD) has introduced two new materials, Certified HX and Certified CuCr2.4, enhancing its materials portfolio for 3D printing. Certified HX is a high-performance nickel alloy, ideal for high-temperature applications up to 1200°C, while Certified CuCr2.4 offers improved strength and conductivity for cooling systems. Both materials are optimized for use with DMP Flex 350 and DMP Factory 350 printers. These innovations aim to meet the increasing demands in industries like energy, aerospace, and automotive, showcasing 3D Systems' commitment to advancing additive manufacturing technology.
3D Systems (NYSE: DDD) has partnered with ALM to include DuraForm® PAx in ALM's materials portfolio. This innovative nylon copolymer is aimed at industrial applications, offering lower costs and high recyclability. DuraForm PAx is engineered for high impact and elongation performance, making it suitable for diverse applications such as orthotics and tooling. The collaboration enhances material options for customers using Selective Laser Sintering (SLS) technologies and signifies a commitment to innovation in additive manufacturing. Both companies will showcase this material at Formnext 2022.
3D Systems Corporation (NYSE: DDD) reported a 15.3% decrease in revenue to $132.3 million for Q3 2022, impacted by divestitures and a decline in dental market sales. Despite challenges, non-GAAP revenue, excluding divestitures, grew 2.7%. The company experienced a net loss of $(37.4) million and a diluted loss per share of $(0.30). Adjusted EBITDA stood at $(0.3) million, reflecting inflationary pressures. Cash and short-term investments totaled $609.4 million. FY 2022 revenue guidance was revised to $535 - $545 million, with improved outlook on operating expenses.
3D Systems (NYSE: DDD) will release its third quarter 2022 financial results after U.S. markets close on November 8, 2022. A conference call and webcast to discuss the results will be held on November 9, 2022, at 8:30 a.m. ET. The company has been a leader in additive manufacturing solutions for over 35 years, serving various industries including healthcare, aerospace, and automotive. Investors can access the webcast and replay through the company's investor relations website.
3D Systems (NYSE: DDD) announced that Amnovis, a Belgium-based additive manufacturing company, has integrated the DMP Flex 350 Dual into its production workflow. This dual-laser solution enhances productivity by at least 50% compared to single-laser systems while reducing costs. Amnovis aims to leverage this technology for high-quality medical devices and industrial applications. The DMP Flex 350 Dual offers flexible application use and efficient management of print jobs, contributing to a competitive edge in both medical and industrial sectors.
3D Systems (NYSE:DDD) will participate in William Blair’s virtual panel, “Advancing Healthcare Through 3D Bioprinting,” on September 23, 2022, at 12:00 p.m. ET. This event highlights advancements in healthcare via 3D printing technology. A recording will be accessible on their website post-event for seven days. With over 35 years of experience, 3D Systems leads in additive manufacturing, offering tailored solutions in diverse sectors like healthcare, aerospace, and automotive.
3D Systems (NYSE:DDD) has announced that Andrew Johnson, executive vice president and chief legal officer, will also serve as chief corporate development officer. This dual role includes overseeing mergers and acquisitions and forging new strategic partnerships. Johnson's extensive experience, including the completion of over 60 M&A transactions, positions him well for these expanded responsibilities. The company aims to capitalize on emerging opportunities in regenerative medicine through strategic partnerships, leveraging its recent acquisitions and technological advancements.
FAQ
What is the current stock price of 3D Systems (DDD)?
What is the market cap of 3D Systems (DDD)?
What does 3D Systems Corp do?
What are the main segments of 3D Systems' business?
What recent innovations has 3D Systems introduced?
How is 3D Systems expanding its digital dentistry portfolio?
What is the significance of 3D Systems' recent debt repurchase?
How does 3D Systems impact the healthcare industry?
What are some of the industries served by 3D Systems?
Where does 3D Systems generate most of its revenue?
What is 3D Systems' approach to supporting customer demand?
How long has 3D Systems been in the 3D printing industry?
